PORTALUPPI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 23.341
AS - Asia 10.019
EU - Europa 6.734
SA - Sud America 1.703
AF - Africa 150
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 12
Totale 41.987
Nazione #
US - Stati Uniti d'America 23.010
SG - Singapore 4.077
CN - Cina 2.817
UA - Ucraina 1.695
BR - Brasile 1.419
IT - Italia 1.321
DE - Germania 1.255
HK - Hong Kong 1.135
TR - Turchia 1.026
GB - Regno Unito 716
FI - Finlandia 492
VN - Vietnam 455
SE - Svezia 412
RU - Federazione Russa 370
MX - Messico 183
IN - India 117
AR - Argentina 114
FR - Francia 109
CA - Canada 108
BD - Bangladesh 78
PL - Polonia 64
ID - Indonesia 63
NL - Olanda 60
JP - Giappone 57
ZA - Sudafrica 57
ES - Italia 55
EC - Ecuador 46
IQ - Iraq 35
AT - Austria 34
CO - Colombia 30
BE - Belgio 28
LT - Lituania 25
AU - Australia 24
VE - Venezuela 24
MA - Marocco 23
PE - Perù 23
CZ - Repubblica Ceca 22
PY - Paraguay 21
PK - Pakistan 19
NG - Nigeria 14
SA - Arabia Saudita 14
CL - Cile 13
KR - Corea 13
KE - Kenya 12
RO - Romania 12
TN - Tunisia 12
UZ - Uzbekistan 12
CH - Svizzera 11
IE - Irlanda 11
JO - Giordania 11
IL - Israele 10
MY - Malesia 10
TT - Trinidad e Tobago 10
EG - Egitto 9
LB - Libano 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 7
PH - Filippine 7
BH - Bahrain 6
CR - Costa Rica 6
EU - Europa 6
OM - Oman 6
UY - Uruguay 6
GA - Gabon 5
HN - Honduras 5
NO - Norvegia 5
BO - Bolivia 4
BY - Bielorussia 4
DZ - Algeria 4
HR - Croazia 4
JM - Giamaica 4
NP - Nepal 4
NZ - Nuova Zelanda 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CY - Cipro 3
DO - Repubblica Dominicana 3
IR - Iran 3
KZ - Kazakistan 3
LV - Lettonia 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AZ - Azerbaigian 2
DK - Danimarca 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
KG - Kirghizistan 2
NI - Nicaragua 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 41.959
Città #
Fairfield 2.739
Woodbridge 2.496
Singapore 2.433
Jacksonville 1.840
Ashburn 1.801
Houston 1.788
Chandler 1.349
Ann Arbor 1.186
Hong Kong 1.127
Seattle 1.062
Santa Clara 1.042
Wilmington 966
Cambridge 846
Beijing 654
Izmir 538
Nanjing 472
Princeton 335
San Diego 250
Los Angeles 248
Boardman 235
Dallas 235
Munich 187
Carrara 176
Ho Chi Minh City 167
Shenyang 158
Milan 150
New York 142
Hefei 130
Mexico City 130
Nanchang 119
São Paulo 118
Helsinki 115
Tianjin 113
Changsha 110
Falls Church 104
Ferrara 100
Hanoi 97
Hebei 94
San Mateo 93
Shanghai 82
Jinan 78
Jiaxing 76
London 76
Washington 73
Addison 68
Norwalk 67
Buffalo 62
Redwood City 55
Warsaw 54
Chicago 52
Moscow 46
Mountain View 46
Tokyo 46
Zhengzhou 43
Brooklyn 41
Kunming 40
Turku 39
Dearborn 37
Rio de Janeiro 36
Philadelphia 35
Orem 34
Rome 34
Saint Petersburg 34
San Francisco 34
Toronto 34
Denver 33
The Dalles 33
Belo Horizonte 32
Haiphong 32
Stockholm 32
Johannesburg 31
Montreal 31
Orange 30
Chennai 29
Council Bluffs 29
Ningbo 29
Verona 29
Boston 28
Atlanta 26
Tappahannock 25
Auburn Hills 24
Brussels 24
Hangzhou 24
Poplar 24
San Jose 24
Curitiba 23
Frankfurt am Main 23
Guangzhou 23
Falkenstein 22
Bremen 21
Quito 21
Taizhou 21
Ankara 20
Brasília 20
Columbus 20
Goiânia 20
Indiana 20
Amsterdam 18
Campinas 18
Mumbai 18
Totale 28.144
Nome #
Chronotherapy of blood pressure medications to improve management of hypertension and reduce vascular risk 339
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 266
Cronofarmacologia e cronoterapia dell'ipertensione arteriosa 264
Administration-time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension 221
Low molecular weight heparins and glomerular filtration rate: A report to be considered 215
Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults 215
Circadian pattern in occurrence of renal colic in an emergency department: analysis of patients' notes 213
Circadian profile of plasma calcitonin gene-related peptide in healthy man 202
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 200
Detection of urinary abnormalities in a community from northern Italy based on the World Kidney Day screening program 195
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 193
Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy 190
Mechanism of influence of PR interval on loudness of first heart sound 189
An improvement in digoxin bioavailability. Studies with soft gelatin capsules containing a solution of digoxin 187
Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure 187
Diurnal and twenty-four hour patterning of human diseases: Acute and chronic common and uncommon medical conditions 187
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 185
The Fast Fourier Transform in the Analysis of the Normal Phonocardiogram 183
Elevated NT-proBNP levels should be interpreted in elderly patients presenting with dyspnea 183
Diurnal and twenty-four hour patterning of human diseases: Cardiac, vascular, and respiratory diseases, conditions, and syndromes 182
Morning preference in onset of symptomatic third-degree atrio-ventricular heart block 181
Estimation of renal function in patients with eating disorders 180
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 178
Out-of-hospital sudden death referring to an emergency department 176
Circadian and circannual rhythmicity in the occurrence of subarachnoid hemorrhage 176
Chronotherapy of hypertension 175
Cardiomechanical effect of k-strophanthoside administered to healthy volunteers by the rectal route 174
Regarding "The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions" 172
Chronobiological aspects of pulmonary thromboembolism 172
Cocaine and acute vascular diseases 170
Circadian disruption: New clinical perspective of disease pathology and basis for chronotherapeutic intervention 170
Circadian rhythmicity in the occurrence of spontaneous acute dissection and rupture of thoracic aorta 170
Circadian variation in onset of acute cardiogenic pulmonary edema is independent of patients' features and underlying pathophysiological causes 169
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects 168
Circadian rhythms in mouse blood coagulation 168
ST segment monitoring as a predictor of reperfusion after blood transfusion in a patient with acute non-Q-wave myocardial infarction 168
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial 168
Diagnosis of mitral valve diseases using indirect (esophageal) left atrial pulse 166
Bioavailability of digoxin improved by pharmaceutical manufactoring process 166
Chronobiologic aspects of ischemic coronary artery disease 166
Estimation of glomerular filtration rate and assessment of risk of stroke in an emergency setting 165
Clinical features of cardio-renal syndrome in a cohort of consecutive patients admitted to an internal medicine ward 164
Evidence-based statin prescription for cardiovascular protection in renal impairment 164
Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide 163
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects 163
Biological Rhythms, Drug Delivery, and Chronotherapeutics 163
Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach 163
Atrial strain is the main determinant of release of atrial natriuretic peptide 161
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 160
Altered circadian rhythms of blood pressure and heart rate in non-hemodialysis chronic renal failure 160
Circadian rhythms and cardiovascular health 159
The main heart sounds as vibrations of the cardiohemic system: old controversy and new facts 158
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes 158
Risk factors for metabolic syndrome in stable Italian renal transplant patients 157
Circadian variation in the occurrence of fatal pulmonary embolism. Differences depending on sex and age 156
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease 156
Chronobiologic vs. sphygmomanometric assessment of hypertension in a hospital setting 155
Risk factors for renal disease and urinary abnormalities in men and women: Data from the world kidney day in the province of Ferrara, Italy 155
Esophageal left atrial pulse in mitral valve prolapse 154
Effect of dermorphin on behavior and hippocampal electrical activity in rabbits 154
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) 154
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design 154
Circadian and cyclic environmental determinants of blood pressure patterning and implications for therapeutic interventions 154
Does placebo lower blood pressure in hypertensive patients? A noninvasive chronobiological study 153
Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure 153
Phonometric study of the human first heart sound 152
Loss of nocturnal blood pressure fall in patients with renal impairment 152
2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM). 151
Pulmonary hypertension in dialysis patients: a cross-sectional Italian study 151
Circadian variation in the onset of acute critical limb ischemia 150
Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease 150
Biological rhythms, medication safety, and women's health 149
Ergometric evaluation of the effects of enalapril maleate in normotensive patients with stable angina 148
Ethics and methods for biological rhythm research on animals and human beings 148
Chronobiological patterns of onset of acute cerebrovascular diseases 148
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 147
SEASONAL VARIATION IN THE RUPTURE OF ABDOMINAL AORTIC ANEURYSMS 146
Dissociated 24-hour patterns of somatotropin and prolactin in fatal familial insomnia 146
Circadian rhythms and medical diseases: Does it matter when drugs are taken? 146
Bedtime hypertension chronotherapy: concepts and patient outcomes 146
Diurnal blood pressure variation and hormonal correlates in fatal familial insomnia 145
Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls 145
Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension 143
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 143
Typical chest pain and onset of acute myocardial infarction in a prospective cohort of emergency calls 142
Night shift and impaired endothelial function: Circadian out-of-synch may play a role 142
Are we overtreating hypertensive patients? Chronobiologic vs. sphygmomanometric evaluation of ambulatory antihypertensive therapy 141
Delta opioid receptor involvement in endocrine pathophysiology 141
Antagonisti del recettore dell’Angiotensina II e scompenso cardiaco. Domande e risposte per il medico pratico 141
Seasonal variation in the occurrence of nontraumatic rupture of thoracic aorta 141
Seasonal variation in the occurrence of epistaxis 140
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 140
Twenty-four-hour pattern of angina pectoris, acute myocardial infarction and sudden cardiac death: role of blood pressure, heart rate and rate-pressure product circadian rhythms 140
Noninvasive index of cardiac contractility during stress testing: a collaborative study 139
Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene 139
Circadian rhythmic and environmental determinants of 24-hour blood pressure regulation in normal and hypertensive conditions 139
Do restless legs syndrome (RLS) and periodic limb movements of sleep (PLMS) play a role in nocturnal hypertension and increased cardiovascular risk of renally impaired patients? 139
Seasonal variations in the rupture of abdominal aortic aneurysms 139
Endocrine mechanisms of blood pressure rhythms 138
Effects of captopril on the physical work capacity of normotensive patients with stable-effort angina pectoris 137
Totale 16.629
Categoria #
all - tutte 189.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 8.634
Totale 197.896


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.311 0 0 0 0 0 451 103 500 58 475 506 218
2021/20223.476 118 427 342 140 143 129 193 206 120 270 395 993
2022/20233.148 362 100 121 395 489 522 83 309 419 20 201 127
2023/20241.232 181 227 76 50 88 92 45 86 16 23 48 300
2024/20255.546 232 149 433 138 728 555 210 421 805 634 728 513
2025/20268.592 1.323 705 1.542 2.166 2.165 691 0 0 0 0 0 0
Totale 42.211